SEC FORM 4CLUSTER · 4 INSIDERS
$210,889.60
Verrica Pharmaceuticals Inc. (VRCA)
Purchase of 42,230 shares across 4 reporting persons.
Transaction Code P · Reporting Persons 4
- Kirby John J., Interim CFOPurchase of 5,000 shares at $4.93 per share.$24,650.00
- Rieger Jayson, CEO and PresidentPurchase of 20,000 shares at $5.06 per share.$101,200.00
- Rieger Jayson, CEO and PresidentPurchase of 5,000 shares at $4.91 per share.$24,550.00
- Rosenberg Noah L., CMOPurchase of 4,200 shares at $4.91 per share.$20,622.00
- Rosenberg Noah L., CMOPurchase of 2,030 shares at $4.92 per share.$9,987.60
- Zawitz David, Chief Operating OfficerPurchase of 6,000 shares at $4.98 per share.$29,880.00
Surfaced by rule: 4 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.
Traded Aug 14, 2026 · Disclosed Aug 18, 2026
Source: SEC Form 4 · 0001556327-26-000003 · filed 2026-08-18 · View filing →
Source: SEC Form 4 · 0002043558-26-000005 · filed 2026-08-18 · View filing →
Source: SEC Form 4 · 0001579649-26-000005 · filed 2026-08-18 · View filing →
Source: SEC Form 4 · 0002046750-26-000004 · filed 2026-08-18 · View filing →